Cancer Treatment Drugs Markets in China (12 Full Research Reports Collection)

  • January 2014
  • -
  • Asia Market Information & Development Company
  • -
  • 2438 pages

China's demand for cancer treatment drugs markets has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow.

This is a collection of 12 full market research reports:

821 Lung Cancer Treatment Drugs Markets in China
822 Breast Cancer Treatment Drugs Markets in China
823 Prostate Cancer Treatment Drugs Markets in China
824 Leukemia Treatment Drugs Markets in China
826 Ovarian Cancer Treatment Drugs Markets in China
827 Colon Cancer Treatment Drugs Markets in China
828 Cervical Cancer Treatment Drugs Markets in China
829 Brain Cancer Treatment Drugs Markets in China
830 Bladder Cancer Treatment Drugs Markets in China
843 Liver Cancer Treatment Drugs Markets in China
844 Kidney Cancer Treatment Drugs Markets in China
845 Skin Cancer Treatment Drugs Markets in China

These new studies examine China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.

Table Of Contents

Cancer Treatment Drugs Markets in China (12 Full Research Reports Collection)

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • January 2015
  • by Global Data

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. ...

Therapeutics for ”Silent” Cancers

Therapeutics for ”Silent” Cancers

  • $ 6 650
  • Industry report
  • February 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014. This market is expected to reach almost $13.6 billion by 2019, with a compound annual ...

A Product and Pipeline Analysis of the Lung Cancer Therapeutics Market : Discovery of New Targeted Therapies will Replace Conventional Therapies

A Product and Pipeline Analysis of the Lung Cancer Therapeutics Market : Discovery of New Targeted Therapies will Replace Conventional Therapies

  • $ 5 000
  • Industry report
  • January 2015
  • by Frost & Sullivan

Executive Summary •The estimated market size for lung cancer therapeutics in 2014 was $ x billion. •There is increasing competition in this market, especially amongst the large pharmaceutical (pharma) ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.